Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Observed Side Effects (From Clinical Trials) In the Lancet 2021 Phase 2 trial (n=706), at the highest 4.5 mg/week dose, 88% of participants reported at least one side effect and 63% reported a GI-specific event
BPC-157 has shown strong results in tendon and ligament healing in rodent models accelerating repair and potentially reducing the extent of surgical intervention needed
What lipotropic injections plausibly contribute is more modest and more defensible: correction of real deficiencies, a tolerable non-stimulant option for patients who cannot or will not take prescription weight loss medication, and a recurring touchpoint that keeps patients engaged with a supervised program
BPC-157 supports angiogenesis and healing processes, TB-500 enhances cell migration and regeneration through actin regulation, and KPV contributes powerful anti-inflammatory effects via melanocortin pathways
